Table 4 Supportive treatment, imaging and humoral examinations in critical patients with HFRS
|  | Survivors (n = 46) | Non-survivors (n = 29) | P valuea |
|---|---|---|---|
Supportive treatment | Â | Â | Â |
RRT, n (%) | 42 (91.3) | 22 (75.9) | .132 |
CRRT, n (%) | 28 (60.9) | 22 (75.9) | .180 |
MV, n (%) | 15 (32.6) | 7 (24.1) | .433 |
Image manifestations | Â | Â | Â |
Pulmonary effusion, n (%) | 31 (62.4) | 17 (58.6) | .441 |
Pleural effusion, n (%) | 28 (60.9) | 11 (37.9) | .053 |
Seroperitoneum, n (%) | 28 (60.9) | 13 (44.8) | .174 |
T-wave change, n (%) | 6 (13) | 3 (10.3) | 1.000 |
Premature ventricular contraction, n (%) | 5 (10.9) | 1 (3.4) | .474 |
Atrial premature beats, n (%) | 3 (6.5) | 4 (13.8) | .518 |
Atrial fibrillation, n (%) | 5 (10.9) | 3 (10.3) | 1.000 |
Pericardial effusion, n (%) | 13 (28.3) | 3 (10.3) | .065 |
Gallbladder swelling, n (%) | 10 (21.7) | 6 (20.7) | .914 |
Humoral examinations | Â | Â | Â |
Urine protein +++ ~ ++++, n (%) | 33 (71.7) | 22 (75.9) | .694 |
Urine occult blood +++ ~ ++++, n (%) | 34 (73.9) | 17 (58.6) | .167 |